These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Letter: Potentiation of warfarin by co-trimoxazole. De Swiet J Br Med J; 1975 Aug; 3(5981):491. PubMed ID: 1156846 [No Abstract] [Full Text] [Related]
4. Drug interaction between co-trimoxazole and warfarin. Greenlaw CW Am J Hosp Pharm; 1979 Sep; 36(9):1155-6. PubMed ID: 495610 [No Abstract] [Full Text] [Related]
5. Combinations of antimicrobial agents. III. The in vitro sensitivity of 12 strains of Pseudomonas aeruginosa and 12 strains of proteus species ot sulphamethoxazole + trimethoprim (co-trimoxazole), polymyxins and combinations of co-trimoxazole and polymyxins. Kuipers JS Arch Chir Neerl; 1976; 28(2):91-9. PubMed ID: 823875 [TBL] [Abstract][Full Text] [Related]
6. Letter: Potentiations of warfarin by co-trimoxazole. Br Med J; 1975 Jun; 2(5972):684. PubMed ID: 1139178 [No Abstract] [Full Text] [Related]
7. Stereoselective interaction of trimethoprim-sulfamethoxazole with the separated enantiomorphs of racemic warfarin in man. O'Reilly RA N Engl J Med; 1980 Jan; 302(1):33-5. PubMed ID: 7350395 [No Abstract] [Full Text] [Related]
9. [In vitro antibacterial effect of sulfamoxole/trimethoprim and sulfamethoxazole/trimethoprim]. Hingst V; Sonntag HG Med Welt; 1979 Aug; 30(33):1199-201. PubMed ID: 491915 [No Abstract] [Full Text] [Related]
10. Potentiation of warfarin by trimethoprim-sulfamethoxazole. Kaufman JM; Fauver HE Urology; 1980 Dec; 16(6):601-3. PubMed ID: 7445308 [TBL] [Abstract][Full Text] [Related]
11. In vitro resistance of haemophilus influenzae to co-trimoxazole and trimethoprim. Cornere BM; Menzies R N Z Med J; 1975 Mar; 81(536):292-4. PubMed ID: 1079587 [TBL] [Abstract][Full Text] [Related]
12. A new antibiotic combination of unusually broad spectrum. Neu HC Med Times; 1973 Sep; 101(9):47-54. PubMed ID: 4730356 [No Abstract] [Full Text] [Related]
13. In-vitro susceptibility of organisms isolated from burns to topical co-trimoxazole. Holder IA J Antimicrob Chemother; 1981 Jun; 7(6):623-7. PubMed ID: 6972942 [No Abstract] [Full Text] [Related]
14. Racemic warfarin and trimethoprim-sulfamethoxazole interaction in humans. O'Reilly RA; Motley CH Ann Intern Med; 1979 Jul; 91(1):34-6. PubMed ID: 464451 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic progress: trimethoprim-sulfamethoxazole. Ruiz López R; Saavedra S; Ramírez-Ronda CH Bol Asoc Med P R; 1984 Jul; 76(7):309-13. PubMed ID: 6332635 [No Abstract] [Full Text] [Related]
16. In vitro interactions between metronidazole or tinidazole and ampicillin, doxycycline and co-trimoxazole on the effect against anaerobic bacteria. Bergan T; Fotland MH Scand J Gastroenterol Suppl; 1984; 91():95-101. PubMed ID: 6610923 [TBL] [Abstract][Full Text] [Related]
18. Modification of hypoglycaemic effect of tolbutamide by co-trimoxazole. Amla V; Kohli K; Sharma JD J Indian Med Assoc; 1988 Mar; 86(3):64-5. PubMed ID: 3260929 [No Abstract] [Full Text] [Related]
19. [Effect of Co-trimoxazole on renal creatinine excretion in man (author's transl)]. Bräutigam M; Froese P; Baethke R; Kessel M Klin Wochenschr; 1979 Jan; 57(2):95-6. PubMed ID: 762950 [TBL] [Abstract][Full Text] [Related]
20. Role of thymidine for the activity of trimethoprim, sulfonamides and their combinations. Then RL Zentralbl Bakteriol A; 1980; 247(4):483-94. PubMed ID: 7006266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]